Sponsor

Beijing Chest Hospital

Clinical research sponsor

Published trials16
Recruiting shown0
Roles2
SourceClinicalTrials.gov

Clinical trials

16 shown
Phase II Study of Adebrelimab, Chemotherapy, and Apatinib for Advanced Pulmonary Neuroendocrine TumorsNCT06764368 · lead sponsor · 2025-01-01
NOT_YET_RECRUITING
Effect of Compound Amino Acid Tablets on Nutritional Status of Patients With Lung CancerNCT05770063 · lead sponsor · 2023-04-15
UNKNOWN
Surufatinib in Combination of Durvalumab and EP/EC in the Firstly-line Treatment of ES-SCLCNCT05668767 · lead sponsor · 2022-12-01
UNKNOWN
A Real-World Study of Pyrotinib Maleate in the Treatment of Advanced/Metastatic Non-Small Cell Lung Cancer With Rare Mutations in HER2NCT05411276 · lead sponsor · 2022-06-30
UNKNOWN
A Study of Camrelizumab Combined With Chemotherapy Sequential Camrelizumab Combined With Apatinib Treatment of Advanced NSCLCNCT04950400 · lead sponsor · 2021-07-07
UNKNOWN
The Efficacy and Drug Resistance Molecular Biology of Apatinib Combined With EGFR-TK1 Treated for Advanced Slow-progressed Non-Small Cell Lung Cancer (NSCLC)NCT03811054 · lead sponsor · 2018-12-01
UNKNOWN
Mesylate Apatinib Combined With Irinotecan in Treatment of Recurrent Small Cell Lung CancerNCT03651219 · lead sponsor · 2018-09-08
UNKNOWN
Optimizing the Therapeutic Dose of Apatinib Mesylate Tablets in Patients With Lung Cancer by Dose Titration：A Real World Exploratory StudyNCT03594682 · lead sponsor · 2018-08-01
UNKNOWN
Endostar Durative Transfusion Combining With Gemcitabine-Cisplatin to Treat Non-Small Cell Lung Cancer (NSCLC)NCT01669707 · lead sponsor · 2011-04-01
UNKNOWN
Befotertinib Plus Chemotherapy With an MRD-guided Adaptive Strategy for Treatment Escalation and Response Optimization in EGFR-mutated NSCLC PatientsNCT07709585 · collaborator · 2026-07-05
NOT_YET_RECRUITING
A Prospective Multicenter Study of the Association Between TCM Syndromes and EGFR-TKI Efficacy in Lung Cancer PatientsNCT07338396 · collaborator · 2026-01-01
NOT_YET_RECRUITING
Real World Study of Efficacy and Safety of Atezolizumab Plus Chemotherapy in Chinese Patients With ES-SCLCNCT04663438 · collaborator · 2020-06-30
UNKNOWN
A Hospital Based Survey on Lung Cancer Related-pain in Northern ChinaNCT03189277 · collaborator · 2017-06-01
UNKNOWN
Uniportal Versus Triportal Thoracoscopic Lobectomy and Sublobectomy for Early Stage Lung CancerNCT02933294 · collaborator · 2015-05-01
UNKNOWN
Comparison of Different Types of Surgery in Treating Patients With Early-stage Non-small Cell Lung CancerNCT02288026 · collaborator · 2014-09-01
UNKNOWN
Gefitinib Versus Vinorelbine/Platinum as Adjuvant Treatment in Stage II-IIIA(N1-N2) NSCLC With EGFR MutationNCT01405079 · collaborator · 2011-09-19
UNKNOWN

Sponsor roles

lead sponsor9
collaborator7

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.